Medically reviewed by William Truswell, MD Key Takeaways Doxycycline is often used for treating moderate to severe ...

Acne is one of the most widespread skin conditions, impacting people of all ages. Medical experts explain how acne forms, why certain areas of the face are high‑risk for popping, and which skincare ha ...

Acne vulgaris Researchers examined the relationship between dairy and acne severity and frequency. A significantly lower frequency of acne, as well as lower rates of severe acne, has been reported ...

Although many topical or systemic antibiotics exist to treat acne vulgaris, the common inflammatory skin disease is not fully treatable. A new article published in The Journal of Clinical and ...

Isotretinoin, commonly referred to as Accutane, is the only approved medical treatment capable of inducing long-term remission of severe acne. Although highly effective, some individuals experience ...

Over 50 million people across the US live with acne, a condition with no cure that often requires chronic treatment Sagimet Biosciences has announced positive results from the trial of its license ...

Among nearly 20 different agents and treatment combinations, topical triple-agent fixed-dose combination (FDC) gel emerged as the most efficacious for moderate-to-severe acne. Researchers who ...

Understanding the Testosterone-Acne Connection If you thought acne breakouts were only a teenage problem, think again.

A look at the most common medications used in patients with acne. Casey Butrus, PharmD: Hilary, we have many different treatment options for acne, different mechanisms of action that have been around ...

Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...

A pimple inside your nose usually isn't serious and can be treated at home. An inflamed hair follicle is a common cause of a pimple in the nose. Avoid picking your nose to reduce the chances of ...

Denifanstat met all endpoints in a Phase 3 acne trial and showed favorable tolerability. Sagimet also launched a Phase 1 trial for TVB-3567. Sagimet Biosciences announced that its oral fatty acid ...